MOS
TTPH

MGO One Seven’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

MGO One Seven’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$0 Sell
2
-3
-60% -$263 ﹤0.01% 1941
2017
Q4 		$1K Buy
+5
New +$640 ﹤0.01% 1739

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

MGO One Seven's TTPH Position: Q1 2018 in Review

MGO One Seven reduced its Tetraphase Pharmaceuticals, Inc. (TTPH) stake by 60% in Q1 2018, selling an estimated $263 and leaving 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1941.

MGO One Seven first reported a position in TTPH in Q4 2017 and has held it in 2 quarters since. The position peaked at $1K in Q4 2017. 94 funds tracked by Wall St. Rank hold TTPH as of Q1 2018.

  • MGO One Seven held 2 shares of Tetraphase Pharmaceuticals, Inc. worth $0 as of Q1 2018.
  • MGO One Seven sold 3 Tetraphase Pharmaceuticals, Inc. shares in Q1 2018, an estimated $263.
  • Tetraphase Pharmaceuticals, Inc. made up ﹤0.01% of MGO One Seven's portfolio in Q1 2018, its #1941 holding.
  • MGO One Seven first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2017 and has held it in 2 quarters since.
  • MGO One Seven's Tetraphase Pharmaceuticals, Inc. position peaked at $1K in Q4 2017.
  • 94 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.